Skip to main content

Table 1 Clinical characteristics and treatment of 10 infants with Takayasu arteritis

From: Clinical observations on infliximab treatment of infantile onset Takayasu arteritis

Case

Sex

Age at onset (m)

Age at diagnosis (m)

Age treated

with IFX (m)

Fever

Hypertension

Vomiting

Rash

Pulselessness

Vascular

bruit

Angiographic

type

Treatment

1

F

2.5

4

4.3

+

+

+

+

V

IFX

2

F

2

2.5

2.7

+

I

IFX

3

F

2.7

3.2

3.5

+

+

V

IFX

4

F

1.5

2

2.3

+

+

III

IFX

5

M

2

2.7

3

+

+

+

V

IFX

6

F

3

5.2

5.7

+

+

V

GC + IFX

7

F

3

3.7

4.2

+

V

GC + IFX

8

F

5.2

5.7

6.3

+

+

V

GC + IFX

9

F

2.2

3

9

+

V

GC + MTX, IFX

10

M

3

4

7

+

+

V

GC + TCZ,

GC + IFX

  1. + represents positive, − represents negative, m means month, IFX infliximab, GC glucocorticoids, MTX  methotrexate, TCZ tocilizumab